Pembrolizumab

WELL DONE, for EMA and FDA this is the best treatment for a relapsing disease after Pt-based Cht.

Map: A patient with Urothelial cancer (1038)
Node: 19693
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Θεραπεία διαβητικού έλκους
  • Tell the patient to read the AVS alone without support.
  • Ο εθελοντής στην είσοδο θέλει να διώξει τον κόσμο που περιμένει.
  • Lab report section 1
  • Ustekinumab
  • Pembrolizumab

Reminder

empty_reminder_msg

FINISH

Time is up